World of DTC Marketing

FEBRUARY 7, 2021

Measuring RNA, DNA quickly. In the call center AI constantly updates the data base in reflection to patient or HCP questions so that call center nurses have answers to the most likely questions. Predictive Forecasting – Predicting an epidemic is one of the key examples of this topic.

Doctor 164

Doctor Doctors Drugs Marketing 164

Worldwide Clinical Trials

JUNE 15, 2022

We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. The pandemic has had a lasting impact on the ability of sites to participate in trials, particularly in the US. We’ve seen resignations across the sites we work with, as medical staff seek employment where they can work remotely.

Gene Therapy 130

Gene Therapy Gene Clinical Trials Clinical Trials 130

Pfizer

AUGUST 15, 2022

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. In preclinical studies, nirmatrelvir did not demonstrate evidence of mutagenic DNA interactions. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir.

Drugs 99

Drugs Vaccination Vaccine In-Vitro 99

Pfizer

DECEMBER 13, 2022

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. In preclinical studies, nirmatrelvir did not demonstrate evidence of mutagenic DNA interactions. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir.

Drugs 110

Drugs Licensing Licensing Production 110

Pfizer

JANUARY 27, 2023

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. In preclinical studies, nirmatrelvir did not demonstrate evidence of mutagenic DNA interactions. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir.

Marketing 75

Marketing Production Drugs Licensing 75

Pfizer

DECEMBER 20, 2022

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. In preclinical studies, nirmatrelvir did not demonstrate evidence of mutagenic DNA interactions. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir.

Drugs 69

Drugs Licensing Licensing Containment 69

Pfizer

NOVEMBER 23, 2022

Nirmatrelvir is designed to inhibit viral replication at a stage known as proteolysis, which occurs before viral RNA replication. In preclinical studies, nirmatrelvir did not demonstrate evidence of mutagenic DNA interactions. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir.

Licensing 40

Licensing Licensing Drugs Manufacturing 40